FDA Seeks Industry Input on Autonomous and Remote-Operated Medical Robots
The FDA is seeking feedback on safety, cybersecurity, and oversight considerations for medical robots that operate autonomously or are controlled remotely.
The FDA is seeking feedback on safety, cybersecurity, and oversight considerations for medical robots that operate autonomously or are controlled remotely.
Unseated internal flow transducer connectors can trigger device reboots and therapy interruptions, prompting updated checkout and handling protocols.
The system uses clinical-grade wearables and algorithms to provide objective data on tremors, sleep, and medication compliance.
The clearance expands the robotic platform to support natural orifice, single-port, and multiport procedures on a single system.
The Food and Drug Administration classifies the recall as the most serious type after reports of touchscreen malfunctions caused by dropped or jarred devices.
Admetsys announced that the FDA has designated its automated glucose control and continuous blood diagnostics system a Breakthrough Device.
The U.S. FDA has proposed banning electrical stimulation devices for self-injurious or aggressive behavior due to significant risks, marking the second attempt at prohibition, with implications including potential treatment transitions for users and a thorough review of updated evidence and expert opinions.